Abirateron acetate
| dc.contributor.author | Richter Igor | cs |
| dc.contributor.author | Dvořák Josef | cs |
| dc.date.accessioned | 2018-09-25T12:18:21Z | |
| dc.date.available | 2018-09-25T12:18:21Z | |
| dc.date.issued | 2017-01-01 | cs |
| dc.format.extent | 4 | cs |
| dc.identifier.issn | 1801-1209 | cs |
| dc.identifier.uri | https://dspace.tul.cz/handle/15240/31800 | |
| dc.language.iso | cze | cs |
| dc.publisher | Farmakon Press | cs |
| dc.publisher.city | Praha | cs |
| dc.relation.ispartofseries | 0 | cs |
| dc.subject | prostate cancer | cs |
| dc.subject | metastasis | cs |
| dc.subject | chemotherapy | cs |
| dc.subject | hormonal therapy | cs |
| dc.subject | targeted hormonal treatment | cs |
| dc.subject | treatment toxicity | cs |
| dc.title | Abirateron acetate | en |
| dc.title | Abirateron acetát | cs |
| local.citation.epage | 733-736 | cs |
| local.citation.spage | 733-736 | cs |
| local.identifier.publikace | 5269 | |
| local.relation.issue | 5 | cs |